1. Home
  2. JTAI vs BMRA Comparison

JTAI vs BMRA Comparison

Compare JTAI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jet.AI Inc.

JTAI

Jet.AI Inc.

HOLD

Current Price

$1.44

Market Cap

6.8M

Sector

Finance

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.58

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JTAI
BMRA
Founded
2018
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
8.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JTAI
BMRA
Price
$1.44
$2.58
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
101.5K
21.5K
Earning Date
11-14-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,584,279.00
$4,884,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$433.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$2.08
52 Week High
$11.77
$10.16

Technical Indicators

Market Signals
Indicator
JTAI
BMRA
Relative Strength Index (RSI) 31.89 57.12
Support Level $1.55 $2.43
Resistance Level $1.69 $2.67
Average True Range (ATR) 0.15 0.13
MACD 0.02 0.05
Stochastic Oscillator 5.87 84.46

Price Performance

Historical Comparison
JTAI
BMRA

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: